Aethlon Medical, Inc.
AEMD
$1.65
-$0.04-2.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.01% | 47.02% | 31.48% | -157.89% | 49.37% |
| Total Depreciation and Amortization | 0.65% | 0.13% | -4.07% | -2.21% | 68.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.56% | -99.83% | 4.78% | 2,953.15% | -84.37% |
| Change in Net Operating Assets | 83.20% | -257.04% | -130.08% | 32.29% | -218.83% |
| Cash from Operations | 6.78% | 25.10% | 1.87% | 34.80% | 15.43% |
| Capital Expenditure | 22.73% | -- | -- | 144.90% | 75.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 22.73% | -- | -- | 144.90% | 75.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 4,974.10% | -100.00% |
| Repurchase of Common Stock | 83.10% | 13.16% | -5.88% | 59.72% | 24.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42,108.45% | 98,550.00% | -100.10% | 5,437.79% | -104.01% |
| Foreign Exchange rate Adjustments | 74.26% | 23.53% | -1,092.31% | -4.35% | -342.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.25% | 194.37% | -147.81% | 127.12% | 7.72% |